Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/1996
12/12/1996WO1996039419A1 Colon specific genes and proteins
12/12/1996WO1996039418A1 Human cystatin e
12/12/1996WO1996039416A1 Gene therapy for pituitary adenoma and other endocrine disorders
12/12/1996WO1996039415A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION
12/12/1996WO1996039196A1 Gene transfer for treating a connective tissue of a mammalian host
12/12/1996WO1996039177A1 Recombinant poxvirus-calicivirus [rabbit hemorrhagic disease virus (rhdv)] compositions and uses
12/12/1996WO1996039162A1 Regulation of eating behavior
12/12/1996WO1996039158A1 Pineal gland specific gene-1
12/12/1996WO1996039154A1 Oligonucleotides having phosphorothioate linkages of high chiral purity
12/12/1996WO1996039036A1 Composition and methods for creating syngeneic recombinant virus-producing cells
12/12/1996WO1996033282A3 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
12/12/1996WO1996020732A3 Non-traumatic administration of gene delivery vehicles
12/12/1996DE19525900C1 Liver-specific adenovirus expression vector
12/12/1996CA2413012A1 Human vascular endothelial growth factor 2
12/12/1996CA2224176A1 Gene transfer for treating a connective tissue of a mammalian host
12/12/1996CA2223957A1 Transforming growth factor alpha hi
12/12/1996CA2223888A1 Human cystatin e
12/12/1996CA2223741A1 Aav directed targeted integration
12/12/1996CA2223733A1 Human hepatoma-derived growth factor-2
12/12/1996CA2223707A1 Novel gene-up regulated in regenerating liver
12/12/1996CA2223421A1 Methods for enhancement of protective immune responses
12/12/1996CA2223419A1 Recombinant poxvirus-calicivirus [rabbit hemorrhagic disease virus (rhdv)] compositions and uses
12/12/1996CA2223282A1 Recombinant poxvirus - cytomegalovirus compositions and uses
12/12/1996CA2223153A1 Regulation of eating behavior
12/12/1996CA2223103A1 Oligonucleotides having phosphorothioate linkages of high chiral purity
12/12/1996CA2223038A1 A c5a-like seven transmembrane receptor
12/12/1996CA2222880A1 Recombinant adenovirus and adeno-associated virus, cell lines, and methods of production and use thereof
12/12/1996CA2222280A1 Human chemokine beta-11 and human chemokine alpha-1
12/12/1996CA2221798A1 Colon specific genes and proteins
12/12/1996CA2221795A1 Colon specific gene and protein
12/12/1996CA2221706A1 G-protein receptor htnad29
12/12/1996CA2221637A1 Human g-protein receptor hcegh45
12/12/1996CA2221604A1 Gene therapy for pituitary adenoma and other endocrine disorders
12/12/1996CA2221274A1 Human g-protein receptor hgber32
12/12/1996CA2221258A1 Use of neuro-derived fetal cell lines for transplantation therapy
12/12/1996CA2220979A1 Human g-protein receptor hpraj70
12/12/1996CA2218329A1 Fibroblast growth factor-11
12/12/1996CA2217301A1 Fibroblast growth factor 15
12/12/1996CA2217229A1 Pineal gland specific gene-1
12/12/1996CA2217216A1 Human chemokine beta-13
12/12/1996CA2212992A1 Fibroblast growth factor-14
12/11/1996EP0747480A1 Oligonucleotides specific for cytokine signal transducer gp130 mRNA
12/11/1996EP0746625A1 Targetable vector particles
12/11/1996EP0746624A1 Vector for liver-specific gene therapy
12/11/1996EP0746614A1 Method and reagent for inhibiting the expression of disease related genes
12/11/1996EP0746343A1 METHODS AND COMPOSITIONS OF A BIOARTIFICIAL KIDNEY SUITABLE FOR USE $i(IN VIVO) OR $i(EX VIVO)
12/11/1996EP0746332A1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof
12/11/1996EP0695305A4 Method of forming oligonucleotides
12/11/1996CN1137567A Autonomic replicative and liver cancer specific expressive guide gene transfer system and its application
12/10/1996US5583033 T lymphocyte precursor
12/10/1996US5582995 Methods of screening for compounds which inhibit the direct binding of Ras to Raf
12/10/1996US5582972 Antisense oligonucleotides to the RAS gene
12/08/1996CA2178526A1 Nucleotide sequence of the mycoplasma genitalium genome, fragments thereof, and uses thereof
12/07/1996CA2178256A1 Oncostatin m induced hematopoiesis
12/05/1996WO1996038591A1 IMPROVED METHOD FOR OBTAINING FULL-LENGTH cDNA SEQUENCES
12/05/1996WO1996038558A2 A human purinergic p2u receptor
12/05/1996WO1996038556A2 Deltap62, variants thereof, amino acid sequences coding therefor and their uses in gene therapy for cancer
12/05/1996WO1996038555A2 Unc-53 from c. elegans and its uses in testing compounds involved in the control fo cell behaviour and pharmaceutical compositions
12/05/1996WO1996038461A1 Cleavage of rna using metal complexes
12/05/1996WO1996038178A1 Allogeneic and xenogeneic transplantation
12/05/1996WO1996038172A1 Connective tissue growth factor
12/05/1996WO1996038168A1 Methods and uses of connective tissue growth factor as an induction agent
12/05/1996WO1996038158A1 Long term maintenance of lymphocytes in vitro
12/05/1996WO1996034099A3 Genetic sequences and proteins related to alzheimer's disease, and uses therefor
12/05/1996CA2222882A1 Long term maintenance of lymphocytes in vitro
12/05/1996CA2222609A1 Methods and uses of connective tissue growth factor as an induction agent
12/05/1996CA2221128A1 Hydrolysis and photocleavage of nucleic acid using a metal complex
12/05/1996CA2220955A1 A novel human purinergic p2u receptor
12/05/1996CA2220530A1 Improved method for obtaining full-length cdna sequences
12/05/1996CA2219861A1 .delta.p62, variants thereof, nucleic acid sequences and uses thereof
12/04/1996EP0745134A1 Nucleic acid delivery system, method of synthesis and uses thereof
12/04/1996EP0745131A1 Targeting gene therapy
12/04/1996EP0745127A1 Control of marek's disease by the inhibition of latency and tumor cell development
12/04/1996EP0745122A1 Galanin receptor, nucleic acids, transformed cells and uses thereof
12/04/1996EP0745121A1 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy
12/04/1996EP0745094A1 Superagonists and antagonists of h il-6, and 3d modelling method for their selection
12/04/1996EP0744956A1 Peptides and methods against diabetes
12/03/1996US5580859 Biological injections into mamalian muscle of dna to express a therapeutic protein, polypeptide or peptide; vaccines; administering a dystrophin gene correcting muscular dystrophy
12/03/1996US5580776 Having genetic material stably incorporated
12/03/1996US5580767 Some of internucleotide linkages within oligonucleotide are phosphorothioate linkages
12/03/1996US5580761 Method of conferring resistance to immunodeficiency viral infection
12/03/1996US5580722 Methods of determining chemicals that modulate transcriptionally expression of genes associated with cardiovascular disease
12/03/1996US5580703 Human adeno-associated virus integration site DNA and uses thereof
12/03/1996US5580558 Delivery of gene products via mesangial cells
11/1996
11/28/1996WO1996037626A1 Position-specific integration of vector constructs into eukaryotic genomes mediated by a chimeric integrase protein
11/28/1996WO1996037625A1 Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of genes into mammalian cells and therapeutic uses thereof
11/28/1996WO1996037623A1 Retroviral vectors
11/28/1996WO1996037616A1 Alphavirus rna replicon systems
11/28/1996WO1996037610A2 Cck-4, a receptor tyrosine kinase, and methods for diagnosis and treatment of cck-4 signal transduction disorders
11/28/1996WO1996037608A1 Novel variants of apolipoprotein a-i
11/28/1996WO1996037235A1 Methods for inhibition of hiv
11/28/1996WO1996037234A1 Intracellular immunization
11/28/1996WO1996037219A1 Abundant extracellular products and methods for their production and use
11/28/1996WO1996037218A1 Parasitic helminth venom allergen antigen 5-like genes and proteins
11/28/1996WO1996037194A1 Delivery vehicles comprising stable lipid/nucleic acid complexes
11/28/1996WO1996037104A1 Compositions and methods for inhibiting fibrogenesis
11/28/1996WO1996029413A3 Dna encoding human papilloma virus type 18
11/28/1996WO1996021734A3 P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
11/28/1996CA2221818A1 Parasitic helminth venom allergen antigen 5-like genes and proteins
11/28/1996CA2221708A1 Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of genes into mammalian cells and therapeutic uses thereof
1 ... 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 ... 870